Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al > Summary
Court Case Number 1:20-cv-01395
Filing Date Oct 16, 2020
Termination Date Feb 22, 2021
Court Delaware District Court
Status Dismissed - Other
JudgesColm F. Connolly
Defendant
Plaintiff Attorneys
13Warner-Lambert Company
Attorney Name: David I. Berl
Williams & Connolly
Warner-Lambert Company
Attorney Name: Christopher J. Mandernach
Williams & Connolly
Warner-Lambert Company
Attorney Name: Seth R. Bowers
Williams & Connolly
Warner-Lambert Company
Attorney Name: Michael Xun Liu
Williams & Connolly
Warner-Lambert Company
Attorney Name: Kevin D. Hoagland-Hanson
Williams & Connolly
Warner-Lambert Company
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Warner-Lambert Company
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Pfizer Legal Division 2
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Pfizer Legal Division 2
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Warner-Lambert Company
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Warner-Lambert Company
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
PF PRISM IMB B.V.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
PF PRISM IMB B.V.
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Defendant Attorneys
2Viatris Inc.
Attorney Name: David E. Moore
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: Stephanie O'Byrne
Potter Anderson & Corroon
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10723730 | Solid forms of a selective CDK4/6 inhibitor | Jul 28, 2020 |
